Antagonist of Growth Hormone-Releasing Hormone Potentiates the Antitumor Effect of Pemetrexed and Cisplatin in Pleural Mesothelioma.

Saved in:
Bibliographic Details
Title: Antagonist of Growth Hormone-Releasing Hormone Potentiates the Antitumor Effect of Pemetrexed and Cisplatin in Pleural Mesothelioma.
Authors: Gesmundo I; Division of Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, 10126 Turin, Italy., Pedrolli F; Division of Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, 10126 Turin, Italy., Vitale N; Molecular Biotechnology Center, Department of Molecular Biotechnology and Health Sciences, University of Turin, 10126 Turin, Italy., Bertoldo A; Division of Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, 10126 Turin, Italy., Orlando G; Department of Oncology, University of Turin, 10126 Turin, Italy., Banfi D; Division of Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, 10126 Turin, Italy., Granato G; Division of Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, 10126 Turin, Italy., Kasarla R; Division of Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, 10126 Turin, Italy., Balzola F; Division of Gastroenterology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, University of Turin, 10126 Turin, Italy., Deaglio S; Department of Medical Sciences, University of Turin, 10126 Turin, Italy.; Immunogenetics and Transplant Biology Service, Città Della Salute e Della Scienza University Hospital, 10126 Turin, Italy., Cai R; Endocrine, Polypeptide, and Cancer Institute, Veterans Affairs Medical Center, Miami, FL 33125, USA.; South Florida VA Foundation for Research and Education, Miami, FL 33125, USA., Sha W; Endocrine, Polypeptide, and Cancer Institute, Veterans Affairs Medical Center, Miami, FL 33125, USA., Papotti M; Department of Oncology, University of Turin, 10126 Turin, Italy.; Pathology Unit, Città Della Salute e Della Scienza University Hospital, 10126 Turin, Italy., Ghigo E; Division of Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, 10126 Turin, Italy., Schally AV; Endocrine, Polypeptide, and Cancer Institute, Veterans Affairs Medical Center, Miami, FL 33125, USA.; South Florida VA Foundation for Research and Education, Miami, FL 33125, USA.; Divisions of Hematology/Oncology and Endocrinology, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL 33101, USA.; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136, USA., Granata R; Division of Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
Source: International journal of molecular sciences [Int J Mol Sci] 2022 Sep 24; Vol. 23 (19). Date of Electronic Publication: 2022 Sep 24.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1422-0067
DOI:10.3390/ijms231911248